Scanning sources…acquiring signal · establishing uplink
Texas-based clinical AI: CDI, autonomous coding, revenue integrity; Advent International-backed.
📍 Austin, Texas, USA
Closed Oct 1, 2025; Iodine integrated under Waystar's clinical-AI segment; founder and CFO retained through transition.
Advent International exits at $1.25B enterprise value after 4-year hold; Iodine becomes the clinical-AI anchor of Waystar's RCM platform.
Definitive agreement signed; Waystar confirmed total enterprise value of $1.25B, financing via existing revolver + new term loan B.
Standard 12-24 month earnout window post-close; watch for vesting-cliff departures Q1 2027.
Briefings · Research · Memos for Iodine Software
Briefings
0None yet — draft one
Deep Research
Memos
0No synthesis memos linked.